• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Actinium Pharmaceuticals Inc

+ Add to Watchlist

ATNM:US

5.8200 USD 0.1700 2.84%

As of 20:04:04 ET on 11/25/2014.

Snapshot for Actinium Pharmaceuticals Inc (ATNM)

Open: 5.9900 Day's Range: 5.7700 - 6.0000 Volume: 48,808
Previous Close: 5.9900 52wk Range: 4.5000 - 15.0000 1-Yr Rtn: -15.65%

Stock Chart for ATNM

No chart data available.
  • ATNM:US 5.8200
  • 1D
  • 1M
  • 1Y
5.9900
Interactive ATNM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATNM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0467
Est. EPS (USD) (12/2014) -0.7900
Est. PEG Ratio -
Market Cap (M USD) 174.63
Shares Outstanding (M) 30.01
30 Day Average Volume 81,510
Price/Book (mrq) 72.6786
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATNM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ATNM

Actinium Pharmaceuticals Inc. operates as a biopharmaceutical company. The Company develops alpha particle immunotherapeutics and other radiopharmaceuticals for select applications.

Sandesh SethChairmanKaushik J DavePresident/CEO/Interim CFO
Dragan CicicCOO/Chief Medical Officer
More Company Profile & Key Executives for ATNM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil